Search

everythinglearnresearchcommunity

for

Search:↓

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Researchers found a new genetic mutation linked to a hair condition in a Japanese boy.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

The Hairless gene is crucial for healthy skin and hair growth.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Accurate diagnosis of APL is crucial to avoid unnecessary treatments.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Mutations in the hairless gene in mice affect its expression and lead to a range of developmental issues in multiple tissues.

Combining scalp reduction and hair transplants improves coverage and appearance for male baldness.

Congenital atrichia with papular lesions causes permanent hair loss and skin bumps from birth.

Trichohyalin may trigger the immune response causing alopecia areata.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

"D-CHRAMPS syndrome" is a newly identified condition with multiple severe symptoms.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

High doses of dihydroartemisinin caused reversible liver toxicity in rats, with females more affected than males.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

PLLA injections can cause hair loss and skin issues.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

Aire mutation reduces alopecia areata, while Notch4 mutation prevents it in mice.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.